Stocks to buy

Editor’s Note: This article is a part of our “Top Grad Stocks 2021” series, where our savvy market analysts recommend their best picks for new graduates’ portfolios. Check out “Money Moves for Recent Grads” for more finance advice and click here to see more stocks for your must-buy list. Source: Ken Wolter / Shutterstock.com With most colleges having concluded the school year
0 Comments
As Republicans in Congress make a new push for federal legalization of cannabis, it’s a good time to hold some quality cannabis stocks. It’s expected that the legal cannabis market could be worth $100 billion in the United States alone by 2030. Further, Canada is already an attractive market and medicinal cannabis is gaining traction
0 Comments
Five of the past eight trading days have ended in the red, driven by fears of inflation. Last week, the market was startled by the news that the Consumer Price Index (CPI) posted its largest month-over-month increase since 2009. Making matters worse was that CPI also had its largest year-over-year rise since 2008. Tech stocks
0 Comments
Cisco Systems (NASDAQ:CSCO) is like your favorite sports team, assuming you’re a real fan and don’t just follow whoever wins. It’s always wait until next year. Since its glory days during the dot-com era, when it was briefly the world’s most valuable company, CSCO stock has been regularly disappointing investors. It’s still about 35% below
0 Comments
Up until last week, shares in renewable biofuels company Gevo (NASDAQ:GEVO) had slumped almost 70% from mid-February highs. For those who believed in the growth potential of the company, this represented a huge buying opportunity. However, after reporting Q1 earnings on May 13, GEVO stock has rallied. Source: Oleksiy Mark / Shutterstock.com More specifically, GEVO popped
0 Comments
It’s fair to say that there’s change afoot at Brooklyn Immunotherapeutics (NYSEAMERICAN:BTX). Some folks are averse to big changes, but BTX stock holders shouldn’t be worried at all. Source: Shutterstock Just to give you a quick rundown, Brooklyn Immunotherapeutics is a clinical-stage biopharmaceutical company. It specializes in developing treatments for patients suffering from cancer and
0 Comments